METHERGINE Drug Patent Profile
✉ Email this page to a colleague
When do Methergine patents expire, and when can generic versions of Methergine launch?
Methergine is a drug marketed by Edison Theraps Llc and is included in one NDA.
The generic ingredient in METHERGINE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methergine
A generic version of METHERGINE was approved as methylergonovine maleate by AM REGENT on November 24th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHERGINE?
- What are the global sales for METHERGINE?
- What is Average Wholesale Price for METHERGINE?
Summary for METHERGINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Clinical Trials: | 9 |
Patent Applications: | 1,535 |
Drug Prices: | Drug price information for METHERGINE |
What excipients (inactive ingredients) are in METHERGINE? | METHERGINE excipients list |
DailyMed Link: | METHERGINE at DailyMed |
Recent Clinical Trials for METHERGINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Columbia University | Phase 4 |
Stony Brook University | Phase 3 |
Johns Hopkins University | Early Phase 1 |
US Patents and Regulatory Information for METHERGINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Edison Theraps Llc | METHERGINE | methylergonovine maleate | INJECTABLE;INJECTION | 006035-004 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Edison Theraps Llc | METHERGINE | methylergonovine maleate | TABLET;ORAL | 006035-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |